Publications

Julie Champion

  • Herrera, EL, Padmore, TJ, Champion, JA. 2016. Bacterial effector nanoparticles as breast cancer therapeutics. Mol Pharm. 13(3):710-9. doi: 10.1021/acs.molpharmaceut.5b00377. Epub 2016 Jan 22. PMID: 26800341
  • Garapaty A, Champion JA. 2015. Biomimetic and synthetic interfaces to tune immune responses.Biointerphases. 10(3):030801. doi: 10.1116/1.4922798.  PMID: 26178262

Michelle Dawson

  • McAndrews KM, McGrail DJ, Ravikumar N, Dawson MR. 2015. Mesenchymal stem cells induce directional migration of invasive breast cancer cells through TGF-β. Sci Rep. 5:16941. doi: 10.1038/srep16941. PMID:26585689
  • McGrail DJ, McAndrews KM, Brandenburg CP, Ravikumar N, Kieu QM, Dawson MR. 2015. Osmotic regulation is required for cancer cell survival under solid stress. Biophys J. 109(7):1334-7. doi: 10.1016/j.bpj.2015.07.046.PMID:26445434
  • McAndrews KM, Yi J, McGrail DJ, Dawson MR. 2015. Enhanced adhesion of stromal cells to invasive cancer cells regulated by cadherin 11. ACS Chem Biol. 10(8):1932-8. doi: 10.1021/acschembio.5b00353. Epub 2015 Jun 17.PMID:26046821
  • McGrail DJ, Khambhati NN, Qi MX, Patel KS, Ravikumar N, Brandenburg CP, Dawson MR. 2015. Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner. Sci Rep. 5:9529. doi: 10.1038/srep09529. PMID:25886093
  • McGrail DJ, Kieu QM, Iandoli JA, Dawson MR. 2015. Actomyosin tension as a determinant of metastatic cancer mechanical tropism. Phys Biol. 12(2):026001. doi: 10.1088/1478-3975/12/2/026001. PMID:25706686
  • McGrail DJ, Mezencev R, Kieu QM, McDonald JF, Dawson MR. 2015.  SNAIL-induced epithelial-to-mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression. FASEB J. 29(4):1280-9. doi: 10.1096/fj.14-257345. Epub 2014 Dec 9. PMID:25491311

Mostafa A. El Sayed

  • Aioub M, El-Sayed MA. 2016. A real-time surface enhanced raman spectroscopy study of plasmonic photothermal cell death using targeted gold nanoparticles. J Am Chem Soc. 138(4):1258-64. doi: 10.1021/jacs.5b10997. Epub 2016 Jan 25.PMID:26746480
  • El-Sayed MA. 2014. Concluding remarks: summary of some of our recent studies in the field of conjugating plasmonic gold nanoparticles to single cancer cells and their molecular and cellular dynamics. Faraday Discuss. 175:305-8. doi: 10.1039/c4fd00213j. PMID:25588759
  • Panikkanvalappil SR, Hira SM, Mahmoud MA, El-Sayed MA. 2014. Unraveling the biomolecular snapshots of mitosis in healthy and cancer cells using plasmonically-enhanced Raman spectroscopy. J Am Chem Soc. 136(45):15961-8. doi: 10.1021/ja506289u. Epub 2014 Nov 3. PMID:25330058
  • Kang B, Austin LA, El-Sayed MA. 2014. Observing real-time molecular event dynamics of apoptosis in living cancer cells using nuclear-targeted plasmonically enhanced Raman nanoprobes. ACS Nano. 8(5):4883-92. doi: 10.1021/nn500840x. Epub 2014 Apr 18. PMID:24708404
  • Ali MR, Panikkanvalappil SR, El-Sayed MA. 2014. Enhancing the efficiency of gold nanoparticles treatment of cancer by increasing their rate of endocytosis and cell accumulation using rifampicin. J Am Chem Soc. 136(12):4464-7. doi: 10.1021/ja4124412. Epub 2014 Mar 12. PMID:24467386

Yuhong Fan

  • Medrzycki M, Zhang Y, Zhang W, Cao K, Pan C, Lailler N, McDonald JF, Bouhassira EE, Fan Y.2014. Histone h1.3 suppresses h19 noncoding RNA expression and cell growth of ovarian cancer cells.Cancer Res. 74(22):6463-73. doi: 10.1158/0008-5472.CAN-13-2922. Epub 2014 Sep 9. PMID:25205099

Facundo Fernandez

  • Jones CM, Monge ME, Kim J, Matzuk MM, Fernández FM. 2015. Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model. J Proteome Res. 14(2):917-27. doi: 10.1021/pr5009948. Epub 2015 Jan 16. PMID:25567202
  • Zang X, Jones CM, Long TQ, Monge ME, Zhou M, Walker LD, Mezencev R, Gray A, McDonald JF, Fernández FM.  2014. Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics. J Proteome Res. 13(7):3444-54. doi: 10.1021/pr500409q. Epub 2014 Jun 25. PMID:24922590

Greg Gibson

  • Gibson G, Powell JE, Marigorta UM. 2015. Expression quantitative trait locus analysis for translational medicine.Genome Med. 7(1):60. doi: 10.1186/s13073-015-0186-7. eCollection 2015. PMID:26110023
  • Gibson G. 2014. Cancer: Directions for the drivers. Nature. 512(7512):31-2. doi: 10.1038/nature13649. Epub 2014 Jul 23. PMID:25079332

King Jordan

  • Niu P, Smagul A, Wang L, Sadvakas A, Sha Y, Pérez LM, Nussupbekova A, Amirbekov A, Akanov AA, Gálvez BG, Jordan IK, Lunyak VV. 2015. Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence. Oncotarget. 6(20):17938-57.PMID:26255627
  • Hu B, Ying X, Wang J, Piriyapongsa J, Jordan IK, Sheng J, Yu F, Zhao P, Li Y, Wang H, Ng WL, Hu S, Wang X, Wang C, Zheng X, Li W, Curran WJ, Wang Y. 2014.  Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene. Cancer Res. 74(8):2283-94. doi: 10.1158/0008-5472.CAN-13-3279. Epub 2014 Feb 20.PMID:24556720

Melissa Kemp

  • Prasanphanich AF, Arencibia CA, Kemp ML. 2014. Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition. Free Radic Biol Med. 76:1-13. doi: 10.1016/j.freeradbiomed.2014.07.032. Epub 2014 Aug 1. PMID:25088330

John McDonald

  • Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity.Mezencev R, Matyunina LV, Jabbari N, McDonald JF.BMC Cancer. 2016 Mar 18.
  • Highly-accurate metabolomic detection of early-stage ovarian cancer.Gaul DA, Mezencev R, Long TQ, Jones CM, Benigno BB, Gray A, Fernández FM, McDonald JF.Sci Rep. 2015 Nov 17.
  • Integrated sequence and expression analysis of ovarian cancer structural variants underscores the importance of gene fusion regulation.Mittal VK, McDonald JF.BMC Med Genomics. 2015 Jul 17
  • Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles. Sengupta A, Mezencev R, McDonald JF, Prausnitz MR.Nanomedicine (Lond). 2015
  • Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids.Sodji QH, Kornacki JR, McDonald JF, Mrksich M, Oyelere AK.Eur J Med Chem. 2015
  • OVCAR-3 spheroid-derived cells display distinct metabolic profiles.Vermeersch KA, Wang L, Mezencev R, McDonald JF, Styczynski MP.PLoS One. 2015 Feb 17
  • Clinical selection criteria can predict futile intervention in patients referred for percutaneous endoscopic gastrostomy insertion.Holt DQ, McDonald JF, Murray ML, Hair C, Devonshire DA, Strauss BJ, Moore GT. Intern Med J. 2015 Jun

Alfred Merrill

  • Park WJ, Brenner O, Kogot-Levin A, Saada A, Merrill AH Jr, Pewzner-Jung Y, Futerman AH. 2015. Development of pheochromocytoma in ceramide synthase 2 null mice. Endocr Relat Cancer. 22(4):623-32. doi: 10.1530/ERC-15-0058. Epub 2015 Jun 25. PMID:26113602

Adegboyega Oyelere

  • Tapadar S, Fathi S, Raji I, Omesiete W, Kornacki JR, Mwakwari SC, Miyata M, Mitsutake K, Li JD, Mrksich M, Oyelere AK. 2015. A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities. Bioorg Med Chem. 23(24):7543-64. doi: 10.1016/j.bmc.2015.10.045. Epub 2015 Nov 2. PMID:26585275
  • Washington AZ, Tapadar S, George A, Oyelere AK. 2015.  Exploiting translational stalling peptides in an effort to extend azithromycin interaction within the prokaryotic ribosome nascent peptide exit tunnel. Bioorg Med Chem. 23(16):5198-209. doi: 10.1016/j.bmc.2015.04.078. Epub 2015 May 6. PMID:26037612
  • Sodji QH, Kornacki JR, McDonald JF, Mrksich M, Oyelere AK. 2015. Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids. Eur J Med Chem. 2015;96:340-59. doi: 10.1016/j.ejmech.2015.04.014. Epub 2015 Apr 8. PMID:25899338

Manu Platt

  • Park KY, Li G, Platt MO. 2015. Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk. Sci Rep. 5:13855. doi: 10.1038/srep13855. PMID:26349896
  • Burton LJ, Smith BA, Smith BN, Loyd Q, Nagappan P, McKeithen D, Wilder CL, Platt MO, Hudson T, Odero-Marah VA.2015. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. Carcinogenesis. 36(9):1019-27. doi: 10.1093/carcin/bgv084. Epub 2015 Jun 10. PMID:26069256

Mark Prausnitz

  • Chakravarty P, Lane CD, Orlando TM, Prausnitz MR. 2016. Parameters affecting intracellular delivery of molecules using laser-activated carbon nanoparticles. Nanomedicine. S1549-9634(16)00004-6. doi: 10.1016/j.nano.2015.12.380. Epub ahead of print. PMID:26772422
  • Sengupta A, Mezencev R, McDonald JF, Prausnitz MR. 2015. Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles. Nanomedicine (Lond). 10(11):1775-84. doi: 10.2217/nnm.15.27. PMID:26080699

Philip Santangelo

  • Roller BT, Munson JM, Brahma B, Santangelo PJ, Pai SB, Bellamkonda RV. 2015. Evans blue nanocarriers visually demarcate margins of invasive gliomas. Drug Deliv Transl Res. 5(2):116-24. doi: 10.1007/s13346-013-0139-x.PMID:25787737

Fatih Sarioglu

  • Liu R, Wang N, Kamili F, Sarioglu AF. 2016. Microfluidic CODES: a scalable multiplexed electronic sensor for orthogonal detection of particles in microfluidic channels. Lab Chip. 16(8):1350-7. doi: 10.1039/c6lc00209a. PMID:27021807
  • Kojić N, Milošević M, Petrović D, Isailović V, Sarioglu AF, Haber DA, Kojić M, Toner M. 2015. A computational study of circulating large tumor cells traversing microvessels. Comput Biol Med. 63:187-95. doi: 10.1016/j.compbiomed.2015.05.024. Epub 2015 Jun 10. PMID:26093786
  • Sarioglu AF, Aceto N, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto DT, Luo X, Bardia A, Wittner BS, Ramaswamy S, Shioda T, Ting DT, Stott SL, Kapur R, Maheswaran S, Haber DA, Toner M. 2015. A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods. 12(7):685-91. doi: 10.1038/nmeth.3404. Epub 2015 May 18. PMID:25984697

Jeffrey Skolnick

  • Dhakshinamoorthy S, Dinh NT, Skolnick J, Styczynski MP. 2015. Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemia. Mol Biosyst. 2015 Sep;11(9):2406-16. doi: 10.1039/c5mb00237k. PMID:26175011

Mark Styczynski

  • Dhakshinamoorthy S, Dinh NT, Skolnick J, Styczynski MP. 2015. Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemia. Mol Biosyst. 11(9):2406-16. doi: 10.1039/c5mb00237k. PMID:26175011
  • Vermeersch KA, Wang L, Mezencev R, McDonald JF, Styczynski MP. 2015. OVCAR-3 spheroid-derived cells display distinct metabolic profiles. PLoS One. 10(2):e0118262. doi: 10.1371/journal.pone.0118262. eCollection 2015.PMID:25688563
  • Vermeersch KA, Wang L, McDonald JF, Styczynski MP. 2014.  Distinct metabolic responses of an ovarian cancer stem cell line. BMC Syst Biol. 2014 Dec 18;8:134. doi: 10.1186/s12918-014-0134-y. PMID:25518943

Susan Thomas

  • Palao-Suay R, Aguilar MR, Parra-Ruiz FJ, Maji S, Hoogenboom R, Rohner NA, Thomas SN, Román JS. 2016. α-Tocopheryl succinate-based amphiphilic block copolymers obtained by RAFT and their nanoparticles for the treatment of cancer. Polym Chem. 7(4):838-850. Epub 2015 Nov 27. PMID:27004068
  • Rohner NA, Thomas SN. 2016. Melanoma growth effects on molecular clearance from tumors and biodistribution into systemic tissues versus draining lymph nodes. J Control Release. 223:99-108. doi: 10.1016/j.jconrel.2015.12.027. Epub 2015 Dec 23. PMID:26721446
  • Oh J, Edwards EE, McClatchey PM, Thomas SN. 2015. Analytical cell adhesion chromatography reveals impaired persistence of metastatic cell rolling adhesion to P-selectin. J Cell Sci. 128(20):3731-43. doi: 10.1242/jcs.166439. Epub 2015 Sep 8. PMID:26349809
  • Rohner NA, McClain J, Tuell SL, Warner A, Smith B, Yun Y, Mohan A, Sushnitha M, Thomas SN. 2015. Lymph node biophysical remodeling is associated with melanoma lymphatic drainage. FASEB J. 29(11):4512-22. doi: 10.1096/fj.15-274761. Epub 2015 Jul 15. PMID:26178165

Eberhard Voit

  • Qi Z, Voit EO. 2014. Identification of cancer mechanisms through computational systems modeling. Transl Cancer Res. 3(3):233-242. PMID:26662197

May Wang

  • Kairdolf BA, Bouras A, Kaluzova M, Sharma AK, Wang MD, Hadjipanayis CG, Nie S. 2016. Intraoperative spectroscopy with ultrahigh sensitivity for image-guided surgery of malignant brain tumors. Anal Chem. 88(1):858-67. doi: 10.1021/acs.analchem.5b03453. Epub 2015 Dec 7. PMID:26587976

Ronghu Wu

  • Chen W, Smeekens JM, Wu R. 2015. Systematic and site-specific analysis of N-sialoglycosylated proteins on the cell surface by integrating click chemistry and MS-based proteomics. Chemical Science, 6(8):4681-4689.
  • Chen W, Smeekens JM, Wu R. 2014. Comprehensive analysis of protein N-glycosylation sites by combining chemical deglycosylation with LC-MS. J Proteome Res. 13(3):1466-73. doi: 10.1021/pr401000c. Epub 2014 Feb 10.

Karen Abbott

  • Guo H, Abbott KL. 2015. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers. Adv Cancer Res. 126:281-303.
  • Allam H, Aoki K, Benigno BB, McDonald JF, Mackintosh SG, Tiemeyer M, Abbott KL. 2015.  Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions. J Proteome Res. 14(1):434-46.
  • Dolezal S, Hester S, Kirby PS, Nairn A, Pierce M, Abbott KL. 2014. Elevated levels of glycophosphatidylinositol (GPI) anchored proteins in serum from human cancers detected by C. septicum alpha toxin. Cancer Biomark. 14(1):55-62.

Nathan Bowen

  • Sheng X, Bowen N, Wang Z. 2016. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.Mol Cancer. 2016 Mar 18;15(1):25. doi: 10.1186/s12943-016-0508-4. PMID:26988096
  • Du F, Li Y, Zhang W, Kale SP, McFerrin H, Davenport I, Wang G, Skripnikova E, Li XL, Bowen NJ, McDaniels LB, Meng YX, Polk P, Liu YY, Zhang QJ. 2016. Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression. Tumour Biol. 2016 Mar 2. [Epub ahead of print] PMID:26935058
  • Pannu V, Rida PC, Ogden A, Turaga RC, Donthamsetty S, Bowen NJ, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak CE, Aneja R. 2015. HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients. Oncotarget. 6(8):6076-91. PMID:25788277
  • Chinaranagari S, Sharma P, Bowen NJ, Chaudhary J. 2015. Prostate cancer epigenome. Methods Mol Biol. 1238:125-40. doi: 10.1007/978-1-4939-1804-1_7. PMID:25421658
  • Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, Osan R, Cantuaria G, Aneja R. 2014. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries. J Ovarian Res. 7:53. doi: 10.1186/1757-2215-7-53. eCollection 2014. PMID:25028599
  • Patel D, Knowell AE, Korang-Yeboah M, Sharma P, Joshi J, Glymph S, Chinaranagari S, Nagappan P, Palaniappan R, Bowen NJ, Chaudhary J. 2014. Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer. Mol Endocrinol. 2014 Aug;28(8):1239-53. doi: 10.1210/me.2014-1100. Epub 2014 Jun 12. PMID:24921661

Michael Pierce

  • Guo H, Nagy T, Pierce M. 2014. Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling. J Biol Chem. 289(45):31534-49. doi: 10.1074/jbc.M114.602680. Epub 2014 Oct 1. PMID:25274627
  • Dolezal S, Hester S, Kirby PS, Nairn A, Pierce M, Abbott KL. 2014. Elevated levels of glycosylphosphatidylinositol (GPI) anchored proteins in plasma from human cancers detected by C. septicum alpha toxin. Cancer Biomark. 14(1):55-62. doi: 10.3233/CBM-130377. PMID:24643042

Ricardo Alvarez

  • Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, Fouad TM, Harano K, Debeb BG, Wu Y, Reuben J, Cristofanilli M, Zuo Z. 2016.  MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol. 29(4):330-46. doi: 10.1038/modpathol.2016.38. Epub 2016 Feb 26. PMID:26916073
  • Kogawa T, Fouad TM, Liu DD, Wu J, Shen Y, Masuda H, Fujii T, Chavez-MacGregor M, Alvarez RH, Hortobágyi GN, Valero V, Ueno NT. 2016. High HER2/Centromeric Probe for chromosome 17 fluorescence in situ hybridization ratio predicts pathologic complete response and survival outcome in patients receiving neoadjuvant systemic therapy with trastuzumab for her2 overexpressing locally advanced breast cancer. Oncologist. 21(1):21-7. doi: 10.1634/theoncologist.2015-0101. Epub 2015 Dec 9. PMID:26659222
  • Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M. 2015.  Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients. Onco Targets Ther. 2015 Nov 11;8:3323-8. doi: 10.2147/OTT.S92443. eCollection 2015. PMID:26648736
  • Roy-Chowdhuri S, de Melo Gagliato D, Routbort MJ, Patel KP, Singh RR, Broaddus R, Lazar AJ, Sahin A, Alvarez RH, Moulder S, Wheler JJ, Janku F, Gonzalez-Angulo AM, Chavez-MacGregor M, Valero V, Ueno NT, Mills G, Mendelsohn J, Yao H, Aldape K, Luthra R, Meric-Bernstam F. 2015. Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing. Am J Clin Pathol. 2015 Nov;144(5):713-21. doi: 10.1309/AJCPWDEQYCYC92JQ. PMID:26486734
  • Fujii T, Le Du F, Xiao L, Kogawa T, Barcenas CH, Alvarez RH, Valero V, Shen Y, Ueno NT. 2015. Effectiveness of an adjuvant chemotherapy regimen for early-stage breast cancer: A systematic review and network meta-analysis. JAMA Oncol. 1(9):1311-8. doi: 10.1001/jamaoncol.2015.3062.  PMID:26402167
  • Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT. 2015. Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res Treat. 2015 Jul;152(2):417. doi: 10.1007/s10549-015-3477-1. PMID:26092296
  • Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT. 2015.  Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res Treat. 152(2):407-16. doi: 10.1007/s10549-015-3436-x. Epub 2015 May 29. Erratum in: Breast Cancer Res Treat. 2015 Jul;152(2):417.  PMID:26017070
  • Mitri Z, Karakas C, Wei C, Briones B, Simmons H, Ibrahim N, Alvarez R, Murray JL, Keyomarsi K, Moulder S. 2015. A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer. Invest New Drugs. 33(4):890-4. doi: 10.1007/s10637-015-0244-4. Epub 2015 May 7. PMID:25947565
  • Kogawa T, Fouad TM, Wei C, Masuda H, Kai K, Fujii T, El-Zein R, Chavez-MacGregor M, Litton JK, Brewster A, Alvarez RH, Hortobagyi GN, Valero V, Theriault R, Ueno NT. 2015.  Association of body mass index changes during neoadjuvant chemotherapy with pathologic complete response and clinical outcomes in patients with locally advanced breast cancer. J Cancer. 6(4):310-8. doi: 10.7150/jca.10580. eCollection 2015. PMID:25767600
  • Goswami RS, Patel KP, Singh RR, Meric-Bernstam F, Kopetz ES, Subbiah V, Alvarez RH, Davies MA, Jabbar KJ, Roy-Chowdhuri S, Lazar AJ, Medeiros LJ, Broaddus RR, Luthra R, Routbort MJ. 2015. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors. Clin Cancer Res. 21(11):2644-51. doi: 10.1158/1078-0432.CCR-14-2391. Epub 2015 Feb 18. PMID:25695693
  • Mego M, Giordano A, De Giorgi U, Masuda H, Hsu L, Giuliano M, Fouad TM, Dawood S, Ueno NT, Valero V, Andreopoulou E, Alvarez RH, Woodward WA, Hortobagyi GN, Cristofanilli M, Reuben JM. 2015. Circulating tumor cells in newly diagnosed inflammatory breast cancer. Breast Cancer Res. 2015 Jan 9;17:2. doi: 10.1186/s13058-014-0507-6. PMID:25572591
  • Mego M, Zuo Z, Gao H, Cohen EN, Giordano A, Tin S, Anfossi S, Jackson S, Woodward W, Ueno NT, Valero V, Alvarez RH, Hortobagyi GN, Khoury JD, Cristofanilli M, Reuben JM. 2015. Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer. Thromb Haemost. 2015 Mar;113(3):593-8. doi: 10.1160/TH14-07-0597. Epub 2014 Nov 6. PMID:25373787

Benedict Benigno

  • Benigno, B.B. 2016. The Ultimate Guide to Ovarian Cancer: Everything You Need to Know About Diagnosis, Treatment and Research, 2nd Edition. Sherryben Publishing House, LLC. Atlanta, GA
  • Gaul DA, Mezencev R, Long TQ, Jones CM, Benigno BB, Gray A, Fernández FM, McDonald JF. 2015. Highly-accurate metabolomic detection of early-stage ovarian cancer. Sci Rep. 5:16351. doi: 10.1038/srep16351. PMID:26573008
  • Allam H, Aoki K, Benigno BB, McDonald JF, Mackintosh SG, Tiemeyer M, Abbott KL. 2015. Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions. J Proteome Res. 14(1):434-46. doi: 10.1021/pr501174p. Epub 2014 Dec 9. PMID:25437919

Guilherme Cantuaria

  • Mittal K, Choi da H, Klimov S, Pawar S, Kaur R, Mitra AK, Gupta MV, Sams R, Cantuaria G, Rida PC, Aneja R. 2016. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas. J Ovarian Res. 9(1):17. doi: 10.1186/s13048-016-0224-0. PMID:26992853
  • Rida PC, Cantuaria G, Reid MD, Kucuk O, Aneja R. 2015. How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity. Cancer Metastasis Rev. 34(4):703-13. doi: 10.1007/s10555-015-9590-0. PMID:26358854
  • Pannu V, Mittal K, Cantuaria G, Reid MD, Li X, Donthamsetty S, McBride M, Klimov S, Osan R, Gupta MV, Rida PC, Aneja R. 2015. Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers. Oncotarget. 6(12):10487-97. PMID:25868856
  • Pannu V, Rida PC, Ogden A, Turaga RC, Donthamsetty S, Bowen NJ, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak CE, Aneja R. 2015. HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients. Oncotarget. 6(8):6076-91. PMID:25788277

Ciro Isidoro

  • Tang H, Sebti S, Titone R, Zhou Y, Isidoro C, Ross TS, Hibshoosh H, Xiao G, Packer M, Xie Y, Levine B. 2015.  Decreased mRNA Expression in human breast cancer is associated with estrogen receptor-negative subtypes and poor prognosis. EBioMedicine. 2(3):255-263. PMID